Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression

  • Juárez Fernández, María
  • Goikoetxea Usandizaga, Naroa
  • Porras Sanabria, David
  • García Mediavilla, María Victoria
  • Bravo, Miren
  • Serrano Maciá, Marina
  • Simón, Jorge
  • Delgado, Teresa C.
  • Lachiondo Ortega, Sofía
  • Martínez Flórez, Susana
  • Lorenzo, Óscar
  • Rincón, Mercedes
  • Varela Rey, Marta
  • Abecia, Leticia
  • Rodríguez, Héctor
  • Anguita, Juan
  • Nistal González, Maria Esther
  • Martínez Chantar, María Luz
  • Sánchez Campos, Sonia
[EN] Background and Aims: Recent studies suggest that mitochondrial dysfunction promotes progression to NASH by aggravating the gut-liver status. However, the underlying mechanism remains unclear. Herein, we hypothesized that enhanced mitochondrial activity might reshape a specific microbiota signature that, when transferred to germ-free (GF) mice, could delay NASH progression. Approach and Results: Wild-type and methylation-controlled J protein knockout (MCJ-KO) mice were fed for 6 weeks with either control or a choline-deficient, L-amino acid–defined, high-fat diet (CDA-HFD). One mouse of each group acted as a donor of cecal microbiota to GF mice, who also underwent the CDA-HFD model for 3 weeks. Hepatic injury, intestinal barrier, gut microbiome, and the associated fecal metabolome were then studied. Following 6 weeks of CDA-HFD, the absence of methylation-controlled J protein, an inhibitor of mitochondrial complex I activity, reduced hepatic injury and improved gut-liver axis in an aggressive NASH dietary model. This effect was transferred to GF mice through cecal microbiota transplantation. We suggest that the specific microbiota profile of MCJ-KO, characterized by an increase in the fecal relative abundance of Dorea and Oscillospira genera and a reduction in AF12, Allboaculum, and [Ruminococcus], exerted protective actions through enhancing short-chain fatty acids, nicotinamide adenine dinucleotide (NAD+) metabolism, and sirtuin activity, subsequently increasing fatty acid oxidation in GF mice. Importantly, we identified Dorea genus as one of the main modulators of this microbiota-dependent protective phenotype. Conclusions: Overall, we provide evidence for the relevance of mitochondria–microbiota interplay during NASH and that targeting it could be a valuable therapeutic approach., SI, Publicación en abierto financiada por el Consorcio de Bibliotecas Universitarias de Castilla y León (BUCLE), con cargo al Programa Operativo 2014ES16RFOP009 FEDER 2014-2020 DE CASTILLA Y LEÓN, Actuación:20007-CL - Apoyo Consorcio BUCLE
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation

  • Juárez Fernández, María
  • Porras Sanabria, David
  • Petrov, Petar
  • Román Sagüillo, Sara
  • García Mediavilla, María Victoria
  • Soluyanova, Polina
  • Martínez Flórez, Susana
  • González Gallego, Javier
  • Nistal González, Maria Esther
  • Jover Atienza, Ramiro
  • Sánchez Campos, Sonia
[EN] Gut microbiota plays a key role in obesity and non-alcoholic fatty liver disease (NAFLD), so synbiotics could be a therapeutic alternative. We aim to evaluate a nutritional intervention together with the administration of the bacteria Akkermansia muciniphila and the antioxidant quercetin in an in vivo model of early obesity and NAFLD. 21-day-old rats were fed with control or high-fat diet for six weeks. Then, all animals received control diet supplemented with/without quercetin and/or A. muciniphila for three weeks. Gut microbiota, NAFLD-related parameters, circulating bile acids (BAs) and liver gene expression were analyzed. The colonization with A. muciniphila was associated with less body fat, while synbiotic treatment caused a steatosis remission, linked to hepatic lipogenesis modulation. The synbiotic promoted higher abundance of Cyanobacteria and Oscillospira, and lower levels of Actinobacteria, Lactococcus, Lactobacillus and Roseburia. Moreover, it favored elevated unconjugated hydrophilic BAs plasma levels and enhanced hepatic expression of BA synthesis and transport genes. A. muciniphila correlated with circulating BAs and liver lipid and BA metabolism genes, suggesting a role of this bacterium in BA signaling. Beneficial effects of A. muciniphila and quercetin combination are driven by gut microbiota modulation, the shift in BAs and the gut-liver bile flow enhancement., SI, This work was supported by grants from Ministerio de Economía y Competitividad/FEDER (BFU2017-87960-R; PID2020-120363RB-I0), Junta de Castilla y León (FEDER) (GRS2126/A/2020; LE063U16; LE017P20), and Instituto de Salud Carlos III (PI17/01089, PI20/00690, cofunded by European Regional Development Fund “A way to achieve Europe”). MJF was supported by a fellowship from Ministerio de Ciencia, Innovación y Universidades (FPU18/06257); DP and SRS by a fellow-ship from Junta de Castilla y León cofunded by the European Social Fund; PP by Sara Borrell Postdoctoral Contract CD18/00158 from the Instituto de Salud Carlos III, cofunded by the European Social Fundation. CIBERehd is funded by the Instituto de Salud Carlos III, Spain.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Effects of Melatonin and Akkermansia muciniphila on the Gut-Liver Axis in a MASLD-Associated Liver Fibrosis Model: An Integrative Multi-Omic Approach

  • González Robles, Alba María
  • San Miguel de Vega, Beatriz
  • Román Sagüillo, Sara Selva de
  • Juárez Fernández, María
  • Mauriz Gutiérrez, José Luis
  • Martínez Flórez, Susana
  • Nistal González, Maria Esther
  • García Mediavilla, María Victoria
  • Sánchez Campos, Sonia
[EN] Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common cause of chronic liver disease worldwide. Fibrosis is the main prognostic factor and the last reversible stage before cirrhosis, yet therapeutic options remain limited. Given the strong contribution of gut dysbiosis to MASLD progression, strategies targeting the gut microbiota are of growing interest. This study aims to evaluate the effect of melatonin, a well-known antioxidant, anti-inflammatory and antifibrotic compound, and Akkermansia muciniphila, a next-generation probiotic, on an MASLD-associated liver fibrosis model. Eight-week-old C57BL/6J mice were fed a control or Western diet supplemented with fructose and intraperitoneal CCl4 to induce liver fibrosis. After eight weeks, the animals received either no intervention, melatonin, A. muciniphila, or both for four weeks. Serum biochemistry, liver histology and gut and liver gene expression were evaluated and multi-omic analyses were performed, including gut microbiota profiling and faecal metabolomics. Statistical analyses assessed intergroup differences and correlations across datasets. Both interventions partially restored gut microbiota composition and functionality and modulated hepatic and intestinal gene expression. Melatonin and A. muciniphila exerted protective effects against MASLD-associated fibrosis, which supports their potential as adjunctive therapeutic strategies to mitigate liver injury through modulation of the gut–liver axis, SI, This work was supported by grants from the Ministerio de Ciencia e Innovación (PID2020-120363RB-I00), Junta de Castilla y León and the European Regional Development Fund (GRS2126/A/2020 and LE017-P20) and CIBERehd, is funded by the Instituto de Salud Carlos III (ISCIII). A.G.-R. was supported by a fellowship from Ministerio de Educación (FPU22/02734). M.J.-F. was supported by a fellowship from the Ministerio de Educación (FPU18/06257). S.R.-S was supported by a Fellowship to Finance the Predoctoral Recruitment of Research Personnel by the Junta of Castilla y Leon